Peter Kolchinsky graduated from Harvard with a Ph.D. in virology in 2001. After graduation he got $4 Million from Vertex Pharma co-founder Rich Aldrich and started picking biotech stocks at RA Capital. In 2002 he broke even when the S&P 500 index lost 22%. By the end of 2003, the initial $4 Million investment became $13 Million. Boston-based RA Capital invests in companies with promising drugs and technologies.
| Fund Name: | RA Capital Management |
| Manager | Peter Kolchinsky |
| Portfolio Value | $2,319,025,000 |
| Change This QTR | +1.35% |
| No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|---|
| 1. | ASND | 4,132,442 | $486,388 | -3% | 20.97% | |
| 2. | WVE | 7,775,207 | $302,067 | +4% | 13.02% | |
| 3. | Synthorx Inc | 9,724,598 | $198,090 | 8.54% | ||
| 4. | ZGNX | 2,382,168 | $131,043 | 5.65% | ||
| 5. | RARX | 4,858,260 | $108,825 | 4.69% |
| Company | Symbol | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2019-04-24 | ||||
| 2019-04-15 | ||||
| 2019-04-10 | ||||
| 2019-02-14 |
We use tracking technologies to enhance your user experience and to provide you service. By using Insider Monkey, you are giving us consent. Learn More
